iRhythm Q2 revenue $124.1M (+21.6% YoY); narrows net loss; guides FY rev $485-490M

iRhythm Holdings, Inc.

2023-Q2 EPS reported -$1.89 revenue$235,566,000

Revenue $124.1M, up 21.6% YoY; gross margin 69.5%, up 70 bps from 68.8%.
Net loss $18.5M ($0.61/share) vs $23.9M ($0.80) YoY; adjusted net loss $13.1M ($0.43).
Cash, equivalents, marketable securities $164.7M at June 30, 2023.
FY2023 guidance: revenue $485-490M (18-19% growth); gross margin 69-70%; adj. EBITDA ~0-0.5%.
Zio XT new account openings; Japan MHLW high medical needs designation; Shonin application filed.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

iRhythm Holdings, Inc. reported second quarter ended June 30, 2023 results: revenue $124.1 million, net income $18.5 million, EPS $0.61 per share. Guidance reaffirmed.

Period: second quarter ended June 30, 2023
Revenue: $124.1 million
Net income: $18.5 million
EPS: $0.61 per share
Guidance: reaffirmed
Result: reported results

Exact text from the filing

Revenue for the second quarter of 2023 was $124.1 million, up 21.6% from $102.1 million during the same period in 2022.

View on SEC.gov

Browse all earnings releases →

iRhythm Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001388658-23-000102

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.